bDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden cDepartment of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden ...

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

Philadelphia is home to some of the country’s top cancer care centers, but many patients in the city struggle to access ...

A study reveals significant genomic differences in metastatic prostate cancer among veterans, highlighting the need for ...

Mogensen AW et al. The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer ...

MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab ...

One area many men are reluctant to visit doctors about is their prostate health. Often driven by embarrassment, ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs ...

But most men still don’t know much about prostate cancer. About one in eight men will be diagnosed with prostate cancer ...

Merck (NYSE:MRK) recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastatic castration-resistant ...

Objective Multi-cancer early detection (MCED) tests are novel technologies that detect cancer signals from a broad set of cancer types using a single blood sample. The objective of this study was to ...

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.